Toggle Offcanvas
...
 
Epirubicin Tenders

Epirubicin Tenders

View Epirubicin tenders, RFPs and contracts. Bid on readily available Epirubicin tenders with the best and most comprehensive tendering platform, since 2002.
Epirubicin is a chemotherapy drug used to treat various cancers, including breast cancer. It belongs to the anthracycline class and works by interfering with cancer cell DNA, preventing their growth and division.

Bidding for Epirubicin tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Epirubicin.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Epirubicin market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Epirubicin tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

7 Live Notices for Epirubicin Tenders

Showing 1 to 7

Object: Electronic Auction - Placed Acquisition Of Cancer Medicines
country Brazil
posting date06 May 2025
deadline20 May 2025
Unauthorized Drugs
country Estonia
posting date18 Apr 2025
deadline23 May 2025
According To The Dk 021: 2015 - 33600000-6 - Pharmaceutical Products (Medicines For The Treatment Of Cancer - 19 Names)
country Ukraine
posting date03 May 2025
deadline17 May 2025
Ceftriaxone, 1 G Injection Powder, Ceftazidime, Injection Powder 1.0 Gr, Cefotaxime, Injection Powder For 1 G, Epirubicin, Solution (Concentrate), 2 Mg/Ml, 25 Ml
country Ukraine
posting date01 May 2025
deadline16 May 2025
Mft_Drug_(Phno.:25136) Epirubicin 50 Mg Inj
country India
posting date09 May 2025
deadline15 May 2025
Epirubicin Hcl 10 Mg Inj , Isosfamide Inj 1G Vial With 3Amp Of 2 Ml Each Mesna , Methotrexate 15Mgpreservative Free 3 Ml Inj , Sunitinib 50 Mg Cap ,Sunitinib 25 Mg Tab , Exemestane 25 Mg Tab , Pegylatedgcsf 6 Mg Inj , Leuprolide 3 75 Mg Inj , Cabazitaxel 60Mg Inj , Cabozatinib 40 Mg Tab , Tab Trifluridine 8 19Mg Tipiracil 20 Mg , Flunarizine 5 Mg Tab ,Pramipexole 0 25 Mg Tab Quantity: 22698
country India
posting date01 May 2025
deadline21 May 2025
Tab Capecitabine , Inj Liposomal Doxorubicin , Injcyclophosphamide , Inj Doxorubicin , Inj Epirubicin , Tabtemozolomide , Injbortezomab , Inj Mesna , Injbevicizumab, Injifophosphamide , Injtrastuzumab , Injtrastuzumabemtansine , Tab Lapatinib , Tab Tamoxifen , Tab Everolimus, Injeribulin , Injadotrastuzumab , Tab Letrozole , Tabpalbociclib , Tab Anastrozole , Injleuprolideasetate ,Injoxaliplatin , Inj 5Fu , Inj Clv , Inj Paclitaxel ,Injnabpaclitaxel , Inj Carboplatin , Inj Cetuximab ,Injirinotecan , Tab Regrofinab , Injpembrolizumab ,Injcisplatin , Injvinorelbine , Egorelis , Injdocetaxel ,Injgemicitabine , Tab Erilotinib , Injpemetrexed , Tabgefitinib , Inj Vincristine , Inj Vinblastine , Tab Remivin ,Injfulvestrant , Tab Ribociclib , Tab Olapariv , Tabenzalutamide , Injtriptoline , Tab Biclutamide , Tababireterone , Injdegorelis , Injmitomycin , Tab Rucaparib ,Injbleomycin , Injritozumab , Injdacarabazine ,Injdenosumab , Inj Albumin , Injocteotridelar , Injzoldronicacid , Apricap Kit , Injpalonsetron , Inj Graffil , Injromiplastin, Injalamin , Tab Megestrol , Protein Powder , Tab Sunitib ,Tab Lorlatinib , Inj Durvalumab Quantity: 107
country India
posting date01 May 2025
deadline22 May 2025

Share Share this page